These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 9516829)
1. Mechanisms of in vivo anti-neuroblastoma activity of human natural IgM. Ollert MW; David K; Vollmert C; Juhl H; Erttmann R; Bredehorst R; Vogel CW Eur J Cancer; 1997 Oct; 33(12):1942-8. PubMed ID: 9516829 [TBL] [Abstract][Full Text] [Related]
2. Growth arrest of solid human neuroblastoma xenografts in nude rats by natural IgM from healthy humans. David K; Ollert MW; Juhl H; Vollmert C; Erttmann R; Vogel CW; Bredehorst R Nat Med; 1996 Jun; 2(6):686-9. PubMed ID: 8640561 [TBL] [Abstract][Full Text] [Related]
3. Human natural immunoglobulin M antibodies induce apoptosis of human neuroblastoma cells by binding to a Mr 260,000 antigen. David K; Ollert MW; Vollmert C; Heiligtag S; Eickhoff B; Erttmann R; Bredehorst R; Vogel CW Cancer Res; 1999 Aug; 59(15):3768-75. PubMed ID: 10446994 [TBL] [Abstract][Full Text] [Related]
4. A novel metastatic animal model reflecting the clinical appearance of human neuroblastoma: growth arrest of orthotopic tumors by natural, cytotoxic human immunoglobulin M antibodies. Engler S; Thiel C; Förster K; David K; Bredehorst R; Juhl H Cancer Res; 2001 Apr; 61(7):2968-73. PubMed ID: 11306475 [TBL] [Abstract][Full Text] [Related]
5. Normal human serum contains a natural IgM antibody cytotoxic for human neuroblastoma cells. Ollert MW; David K; Schmitt C; Hauenschild A; Bredehorst R; Erttmann R; Vogel CW Proc Natl Acad Sci U S A; 1996 Apr; 93(9):4498-503. PubMed ID: 8633097 [TBL] [Abstract][Full Text] [Related]
6. Initial characterization of the apoptosis-inducing receptor for natural human anti-neuroblastoma IgM. David K; Heiligtag S; Ollert MW; Teppke M; Vogel CW; Bredehorst R Med Pediatr Oncol; 2001 Jan; 36(1):251-7. PubMed ID: 11464898 [TBL] [Abstract][Full Text] [Related]
7. Treatment of neuroblastoma with human natural antibodies. Erttmann R Autoimmun Rev; 2008 Jun; 7(6):496-500. PubMed ID: 18558369 [TBL] [Abstract][Full Text] [Related]
8. Cloning of a human antibody directed against human neuroblastoma cells and specific for human translation elongation factor 1alpha. Schilbach K; Kreyenberg H; Geiselhart A; Niethammer D; Handgretinger R Tissue Antigens; 2004 Feb; 63(2):122-31. PubMed ID: 14705983 [TBL] [Abstract][Full Text] [Related]
9. [Natural human IgM-antibodies in neuroblastoma therapy: preliminary findings of a phase I/II clinical trial]. Schmitt C; David K; Hiller J; Schrum J; Bredehorst R; Vogel CW; Löliger C; Erttmann R Klin Padiatr; 1999; 211(4):314-8. PubMed ID: 10472569 [TBL] [Abstract][Full Text] [Related]
10. Anti-GM(2) IgM antibody-induced complement-mediated cytotoxicity in patients with dysimmune neuropathies. Cavanna B; Jiang H; Allaria S; Carpo M; Scarlato G; Nobile-Orazio E J Neuroimmunol; 2001 Mar; 114(1-2):226-31. PubMed ID: 11240036 [TBL] [Abstract][Full Text] [Related]
11. Distribution of natural antibody against human neuroblastoma among children with or without neuroblastoma. Fukuda M; Nozaki C; Ishiguro Y; Horibe K Med Pediatr Oncol; 2001 Jan; 36(1):147-8. PubMed ID: 11464870 [TBL] [Abstract][Full Text] [Related]
12. Expression of a 260 kDa neuroblastoma surface antigen, the target of cytotoxic natural human IgM: correlation to MYCN amplification and effects of retinoic acid. David K; Ehrhardt A; Ollert MW; Erttmann R; Bredehorst R; Vogel CW Eur J Cancer; 1997 Oct; 33(12):1937-41. PubMed ID: 9516828 [TBL] [Abstract][Full Text] [Related]
13. Naturally occurring humoral cytotoxicity against neuroblastoma (NB) cells in healthy persons and NB patients. Erttmann R; Schmitt C; Ollert MW; David K; Bredehorst R; Vogel CW Pediatr Hematol Oncol; 1996; 13(6):545-8. PubMed ID: 8940738 [TBL] [Abstract][Full Text] [Related]
14. Determination of antibody-complement mediated cytotoxicity using ATP release induced by a monoclonal antibody against the Burkitt lymphoma associated globotriaosylceramide antigen. Wils P; Junqua S; Le Pecq JB J Immunol Methods; 1986 Mar; 87(2):217-22. PubMed ID: 2419453 [TBL] [Abstract][Full Text] [Related]
15. Cytotoxic activity against human neuroblastoma and melanoma cells mediated by IgM antibodies derived from peripheral blood of healthy donors. Devarapu SK; Mamidi S; Plöger F; Dill O; Blixt O; Kirschfink M; Schwartz-Albiez R Int J Cancer; 2016 Jun; 138(12):2963-73. PubMed ID: 26830059 [TBL] [Abstract][Full Text] [Related]
16. The cytolysis of human neuroblastoma cells by a natural IgM 'antibody'-complement system in pregnancy serum. Bolande RP; Mayer DC Cancer Invest; 1990; 8(6):603-11. PubMed ID: 2292053 [TBL] [Abstract][Full Text] [Related]
17. Immunotherapeutic strategies in neuroblastoma: antitumoral activity of deglycosylated Ricin A conjugated anti-GD2 antibodies and anti-CD3xanti-GD2 bispecific antibodies. Manzke O; Russello O; Leenen C; Diehl V; Bohlen H; Berthold F Med Pediatr Oncol; 2001 Jan; 36(1):185-9. PubMed ID: 11464879 [TBL] [Abstract][Full Text] [Related]
18. Circulating immune complexes in human neuroblastoma: direct assay and role in blocking specific cellular immunity. Jose DG; Seshadri R Int J Cancer; 1974 Jun; 13(6):824-38. PubMed ID: 4136591 [No Abstract] [Full Text] [Related]
19. Immunologic considerations in the use of cultured porcine hepatocytes as a hybrid artificial liver. Anti-porcine hepatocyte human serum. Takahashi M; Ishikura H; Takahashi C; Nakajima Y; Matsushita M; Matsue H; Sato K; Sato K; Noto H; Taguchi K ASAIO J; 1993; 39(3):M242-6. PubMed ID: 8268536 [TBL] [Abstract][Full Text] [Related]